# Liothyronine Sodium

NDC: 43063-884
Generic name: Liothyronine Sodium
Labeler / Manufacturer: PD-Rx Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20121203

FDA application: ANDA200295

## Active ingredients

- LIOTHYRONINE SODIUM: 25 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43063-884"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43063-884
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=76fa4eb6-fefa-4e97-9543-f81e465743e6